(KMB) Kimberly-Clark - Ratings and Ratios
Diapers, Wipes, Tissue, Towels, Soaps, Sanitizers
KMB EPS (Earnings per Share)
KMB Revenue
Description: KMB Kimberly-Clark
Kimberly-Clark Corporation is a leading manufacturer of personal care products, operating through three main segments: North America, International Personal Care, and International Family Care and Professional. The company offers a diverse range of products, including disposable diapers, feminine care products, and household tissue products, under well-known brand names such as Huggies, Kotex, and Kleenex.
The companys business model is focused on providing essential products to consumers, with a strong presence in both developed and emerging markets. To evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, operating margin, and return on equity (ROE) can be used. Notably, KMBs ROE of 226.04% indicates a high level of profitability. Additionally, the companys dividend yield and payout ratio can be examined to assess its ability to generate consistent returns for shareholders.
From a competitive standpoint, KMB operates in a relatively stable industry, with a strong brand portfolio and significant market share. The companys ability to maintain its pricing power and manage input costs will be crucial in driving future profitability. Key metrics to monitor include the companys gross margin, SG&A expenses as a percentage of sales, and cash flow generation. Furthermore, KMBs commitment to innovation and product development, as well as its e-commerce capabilities, will be important factors in driving long-term growth.
In terms of valuation, KMBs price-to-earnings (P/E) ratio of 17.98 and forward P/E of 18.66 can be compared to its peers and the broader market to assess its relative attractiveness. The companys market capitalization of $43.8 billion and enterprise value can also be evaluated to determine its overall size and financial structure.
KMB Stock Overview
| Market Cap in USD | 42,465m |
| Sub-Industry | Household Products |
| IPO / Inception | 1984-12-17 |
KMB Stock Ratings
| Growth Rating | 21.6% |
| Fundamental | 65.0% |
| Dividend Rating | 47.9% |
| Return 12m vs S&P 500 | -22.1% |
| Analyst Rating | 3.26 of 5 |
KMB Dividends
| Dividend Yield 12m | 3.86% |
| Yield on Cost 5y | 4.03% |
| Annual Growth 5y | 2.66% |
| Payout Consistency | 37.3% |
| Payout Ratio | 72.6% |
KMB Growth Ratios
| Growth Correlation 3m | 26.2% |
| Growth Correlation 12m | -16.7% |
| Growth Correlation 5y | 63% |
| CAGR 5y | 5.45% |
| CAGR/Max DD 3y | 0.29 |
| CAGR/Mean DD 3y | 0.72 |
| Sharpe Ratio 12m | -0.01 |
| Alpha | -21.92 |
| Beta | 0.499 |
| Volatility | 20.68% |
| Current Volume | 1442.3k |
| Average Volume 20d | 2027.3k |
| Stop Loss | 124.1 (-3%) |
| Signal | -1.30 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.43b TTM) > 0 and > 6% of Revenue (6% = 1.13b TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -4.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -8.55% (prev -5.24%; Δ -3.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 2.87b > Net Income 2.43b (YES >=105%, WARN >=100%) |
| Net Debt (6.61b) to EBITDA (3.89b) ratio: 1.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (333.3m) change vs 12m ago -1.39% (target <= -2.0% for YES) |
| Gross Margin 35.21% (prev 35.98%; Δ -0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 110.9% (prev 117.4%; Δ -6.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.60 (EBITDA TTM 3.89b / Interest Expense TTM 262.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.85
| (A) -0.10 = (Total Current Assets 5.56b - Total Current Liabilities 7.17b) / Total Assets 16.77b |
| (B) 0.57 = Retained Earnings (Balance) 9.49b / Total Assets 16.77b |
| (C) 0.18 = EBIT TTM 3.04b / Avg Total Assets 17.03b |
| (D) 0.42 = Book Value of Equity 6.46b / Total Liabilities 15.37b |
| Total Rating: 2.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.98
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 4.28% = 2.14 |
| 3. FCF Margin 11.13% = 2.78 |
| 4. Debt/Equity 5.70 = -2.50 |
| 5. Debt/Ebitda 1.86 = 0.27 |
| 6. ROIC - WACC 22.13% = 12.50 |
| 7. RoE 216.1% = 2.50 |
| 8. Rev. Trend -63.16% = -3.16 |
| 9. Rev. CAGR -6.80% = -1.13 |
| 10. EPS Trend 28.01% = 0.70 |
| 11. EPS CAGR 3.74% = 0.37 |
What is the price of KMB shares?
Over the past week, the price has changed by -1.38%, over one month by -3.10%, over three months by -1.09% and over the past year by -7.90%.
Is Kimberly-Clark a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KMB is around 124.10 USD . This means that KMB is currently overvalued and has a potential downside of -3.04%.
Is KMB a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 12
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the KMB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 142.5 | 11.3% |
| Analysts Target Price | 142.5 | 11.3% |
| ValueRay Target Price | 136.3 | 6.5% |
Last update: 2025-09-15 04:39
KMB Fundamental Data Overview
CCE Cash And Equivalents = 634.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 17.5089
P/E Forward = 16.1551
P/S = 2.1536
P/B = 33.4103
P/EG = 5.052
Beta = 0.334
Revenue TTM = 18.88b USD
EBIT TTM = 3.04b USD
EBITDA TTM = 3.89b USD
Long Term Debt = 6.47b USD (from longTermDebt, last quarter)
Short Term Debt = 771.0m USD (from shortTermDebt, last quarter)
Debt = 7.24b USD (Calculated: Short Term 771.0m + Long Term 6.47b)
Net Debt = 6.61b USD (from netDebt column, last quarter)
Enterprise Value = 49.07b USD (42.46b + Debt 7.24b - CCE 634.0m)
Interest Coverage Ratio = 11.60 (Ebit TTM 3.04b / Interest Expense TTM 262.0m)
FCF Yield = 4.28% (FCF TTM 2.10b / Enterprise Value 49.07b)
FCF Margin = 11.13% (FCF TTM 2.10b / Revenue TTM 18.88b)
Net Margin = 12.87% (Net Income TTM 2.43b / Revenue TTM 18.88b)
Gross Margin = 35.21% ((Revenue TTM 18.88b - Cost of Revenue TTM 12.23b) / Revenue TTM)
Tobins Q-Ratio = 7.60 (Enterprise Value 49.07b / Book Value Of Equity 6.46b)
Interest Expense / Debt = 0.93% (Interest Expense 67.0m / Debt 7.24b)
Taxrate = 19.30% (565.0m / 2.93b)
NOPAT = 2.45b (EBIT 3.04b * (1 - 19.30%))
Current Ratio = 0.77 (Total Current Assets 5.56b / Total Current Liabilities 7.17b)
Debt / Equity = 5.70 (Debt 7.24b / last Quarter total Stockholder Equity 1.27b)
Debt / EBITDA = 1.86 (Net Debt 6.61b / EBITDA 3.89b)
Debt / FCF = 3.44 (Debt 7.24b / FCF TTM 2.10b)
Total Stockholder Equity = 1.12b (last 4 quarters mean)
RoA = 14.49% (Net Income 2.43b, Total Assets 16.77b )
RoE = 216.1% (Net Income TTM 2.43b / Total Stockholder Equity 1.12b)
RoCE = 40.00% (Ebit 3.04b / (Equity 1.12b + L.T.Debt 6.47b))
RoIC = 28.95% (NOPAT 2.45b / Invested Capital 8.47b)
WACC = 6.82% (E(42.46b)/V(49.71b) * Re(7.85%)) + (D(7.24b)/V(49.71b) * Rd(0.93%) * (1-Tc(0.19)))
Shares Correlation 3-Years: -54.28 | Cagr: -0.14%
Discount Rate = 7.85% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.09% ; FCFE base≈2.41b ; Y1≈2.75b ; Y5≈3.79b
Fair Price DCF = 197.8 (DCF Value 65.62b / Shares Outstanding 331.8m; 5y FCF grow 16.42% → 3.0% )
Revenue Correlation: -63.16 | Revenue CAGR: -6.80%
Rev Growth-of-Growth: -8.37
EPS Correlation: 28.01 | EPS CAGR: 3.74%
EPS Growth-of-Growth: -20.16
Additional Sources for KMB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle